For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Community
Treatment
- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Treatment Centers
- Chemotherapy
- Immunotherapy
- Monoclonal Antibodies
- Radiotherapy
- Radioimmunotherapy
Understand
- Where to Start
- What is Lymphoma?
- The Lymphatic System
- Lymphoma Symptoms
- Lymphoma Causes
- Lymphoma Prognosis
- Lymphoma Stages
- Refractory/Relapsed Lymphoma
- Indolent lymphoma













Ross, what were the reported
Ross, what were the reported risks? Do we know?
I'll look it up, but unless
I'll look it up, but unless Roche received public funds to run this trial, the data may not be available to the public. Generally the drug companies aren't keen to release negative data like this, so if they don't have to, they probably won't. But if there's public money involved, then the data should be available, if not published anywhere, then through the Freedom of Information Act.
Sadly, Ross is spot on here.
Sadly, Ross is spot on here. Public funds are needed to keep this from being proprietary if it does in fact work out.
Gerald